News summary

Sustained microparticle-mediated intracellular immunomodulation enhances tolerogenic dendritic cell stability and antigen-specific Treg induction

Source: Frontiers - Health • Published: 14 Sept 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

A biodegradable microparticle system co-delivers combinatorial immunomodulators and antigen to stabilize tolerogenic dendritic cells and boost antigen-specific regulatory T cells.

Sustained microparticle-mediated intracellular immunomodulation enhances tolerogenic dendritic cell stability and antigen-specific Treg induction
Key Takeaways
  • PLGA microparticles co-loaded with R848, CEP-33779, and ovalbumin released cargo intracellularly for up to 30 days.
  • Dendritic cells that phagocytosed these particles showed increased PD-L1 and IL-10 and resisted inflammatory reprogramming.
  • Adoptively transferred particle-treated DCs persisted in draining lymph nodes up to seven days and induced antigen-specific Foxp3+ Tregs.
Read the full article at Frontiers - Health

Continue exploring

Recommended MoL Picks

MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.